About Alfa Corpuscles
Alfa Corpuscles is a Healthcare company based in Delhi (India) founded in 2007. Alfa Corpuscles is engaged in manufacturing innovative medical devices. It operates on a Direct-to-Consumer (D2C) and Reseller / Distribution model. Alfa Corpuscles has raised $836.02 thousand across 2 funding rounds from investors including Gujarat Venture Finance, Binoy Gardi and Chanderkant Patel. The company has 4 employees. Alfa Corpuscles was last valued at $3.45 million in January 2015. Its Indian entity Alfa Corpuscles Private Limited reported revenue of ₹2.01 Cr. Alfa Corpuscles offers products and services including Disposable Laparoscopy Access Trocar, Sterile Disposable Skin Stapler, Sterile Disposable Skin Staple Remover, and Hernia Mesh System. Its focus areas include Medical Devices and Surgical Instruments.
Company details
Alfa Corpuscles is involved in the innovation, design, manufacture, and sale of high-quality disposable medical devices. Based in New Delhi, India, the company focuses on healthcare solutions, particularly in the field of surgical consumables. Products such as Disposable Laparoscopy Access Trocars, Sterile Disposable Skin Staplers, Staple Removers, and Hernia Mesh Systems are developed to cater to patient needs. Advanced manufacturing facilities with clean rooms and in-house RD are utilized to ensure consistent quality and innovation in the medical sector.
- Headquarters Delhi, India
- Employees 4
- Stage Minicorn
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website alfacorpuscles.com
- Social LinkedIn
- Legal Name Alfa Corpuscles Private Limited
- Date of Incorporation 08 May, 2007
- Jurisdiction Delhi, India
- Annual Revenue₹2.01 Cr
FY 2024 · +41% YoY
- Net Profit₹2.2 Lakh
FY 2024 · 1% margin
- EBITDA₹17.1 Lakh
FY 2024 · 9% margin
- Total Equity Funding$836.02K (USD)
in 2 rounds
- Latest Funding Round$161.48K (USD), Seed
Jan 2015
- InvestorsGujarat Venture Finance
& 3 more
- Employee Count4
Associated legal entities of Alfa Corpuscles
Alfa Corpuscles operates through Alfa Corpuscles Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2024) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Alfa Corpuscles Private Limited CIN U29294DL2007PTC163078 | Active | 08 May 2007 | Delhi, Delhi | ₹2.0 Cr | 4 | 2 | View details |
Products & Services of Alfa Corpuscles
Alfa Corpuscles offers a comprehensive portfolio of products and services, including Disposable Laparoscopy Access Trocar, Sterile Disposable Skin Stapler, Sterile Disposable Skin Staple Remover, and Hernia Mesh System.
Used for minimally invasive surgical access procedures.
Utilized for rapid and aesthetic skin closure solutions.
Employed to safely remove skin staples post-surgery.
Designed for hernia repair with varied mesh options.
Funding Insights of Alfa Corpuscles
Alfa Corpuscles has successfully raised a total of $836.02K across 2 strategic funding rounds. The most recent funding activity was a Seed round of $161.48 thousand completed in January 2015. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $836,015
- Total Rounds 2
- Last Round Seed — $161,484
- First Round $674,531
(Nov 2012)
- Investors Count 4
All 2 funding rounds of Alfa Corpuscles with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jan 2015 | $161,484 | Seed | $3.45M | Gujarat Venture Finance | – |
| Nov 2012 | $674,531 | Seed | $3.25M | Gujarat Venture Finance |
| Date | Valuation | Stage |
|---|---|---|
| Jan 2015 | $3.45M | •••••••• |
| Nov 2012 | $3.25M | •••••••• |
Last known valuation $3.45M (Jan 2015). 4 investors in total: 1 institutional and 3 angel.
Investors in Alfa Corpuscles
Alfa Corpuscles has secured backing from 4 investors, including venture fund and angel investors. Prominent investors backing the company include Gujarat Venture Finance, Binoy Gardi and Chanderkant Patel.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Venture capital investments are made in Indian startups across multiple sectors. | 1990 | gvfl.com | Ahmedabad, India | |
BG Binoy Gardi | Angel investor, co-founder of iCubesWire, focusing on tech and digital startups | – | unknown_e972950bb8454104a | - |
CP Chanderkant Patel | - | – | unknown_68892f2ffeba432a9 | - |
HN Harsh Navinchandra Raval | - | – | unknown_9eb8ab5d058445ba8 | - |
Investor details for Alfa Corpuscles
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Board of directors of Alfa Corpuscles Private Limited (Alfa Corpuscles)
Alfa Corpuscles Private Limited is the primary company behind Alfa Corpuscles. The board of Alfa Corpuscles Private Limited currently have 2 directors; the longest-serving is Atul Sardana, appointed in 2007. 6 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Atul Sardana DIN 01368799 | Whole-time director | 08 May 2007 | 19 yrs 5 mo | Alfa Corpuscles Private Limited |
| Mihirkumar Arvind Joshi DIN 00823615 | Nominee Director | 07 Aug 2018 | 8 yrs 2 mo | Alfa Corpuscles Private Limited |
Financials of Alfa Corpuscles
Figures of Alfa Corpuscles Private Limited, the primary company behind Alfa Corpuscles, for FY 2024. Revenue was ₹2.01 Cr (+41% year on year). Net profit was ₹2.2 Lakh (1% margin). EBITDA was ₹17.1 Lakh (9% margin). Revenue has grown at a compounded annual rate of +24% over three years and +6% over five years.
- ₹2.01 CrRevenue · FY 2024 · +41% YoY
- ₹2.2 LakhNet profit · 1% margin
- ₹17.1 LakhEBITDA · 9% margin
- ₹71.7 LakhPaid-up capital
- 4Employees (provident fund records)
- +24%Revenue CAGR, 3 years
- +6%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Alfa Corpuscles Private Limited are on its company page.
Detailed financial statements for Alfa Corpuscles
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Timeline of Alfa Corpuscles
4 dated milestones of Alfa Corpuscles across 8 years, from founding to its latest funding, stage changes and deals.
- Founded Alfa Corpuscles is founded.
- Funding First funding round of $675K.
- Milestone Reaches Minicorn status.
- Funding Latest funding round, Seed, of $161K.
Top companies in Medical Equipment & Supplies
10 companies that operate in the same segment as Alfa Corpuscles (Medical Equipment & Supplies), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Software and integrated solutions for surgical and radiotherapy applications | 1989 | Munchen, Bayern, Germany | USD 5.38 M | USD 1.18 M | 18 | |
Robotic waterjet system for prostate tissue removal is developed. | 2009 | Redwood City, California, United States | USD 348.84 M | USD 308.05 M | 756 | |
Collaborative surgical robotic systems are provided for hospital procedures. | 2014 | Cambridge, Cambridgeshire, United Kingdom | USD 1.68 B | USD 48.75 M | 680 | |
Robotic microsurgical systems for endoscopy are developed. | 2007 | Redwood City, California, United States | USD 733.62 M | – | 91 | |
Augmented reality systems for guiding surgical procedures are developed. | 2014 | Yokneam Illit, North District, Israel | USD 142.6 M | – | – | |
Manufacturer of imaging and surgical products | 1919 | Tokyo, Tokyo, Japan | – | USD 6.49 B | 35,933 | |
Injectable packaging, containment, and delivery solutions are manufactured. | 1923 | Exton, Pennsylvania, United States | – | USD 3.07 B | 10,600 | |
Rapid infusion systems are provided for critically ill patients. | 2012 | Durham, North Carolina, United States | USD 77.98 M | – | – | |
Mobile robots are manufactured for industries including healthcare and agriculture. | 2013 | Odense, Denmark | USD 81.44 M | – | 303 | |
Visualization systems for surgical procedures are developed using machine learning. | 2016 | Seattle, Washington, United States | USD 74.25 M | – | 52 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Alfa Corpuscles
Alfa Corpuscles was founded in 2007 and raised its 1st funding round 5 years after it was founded.
Alfa Corpuscles is headquartered in Delhi, India. It is registered at Delhi, Delhi, India.
Alfa Corpuscles is a funded company, having raised a total of $836.02K across 2 funding rounds to date. The company's 1st funding round was a Seed of $674.53K, raised on Nov 2012.
Alfa Corpuscles has 4 employees.
The primary company behind Alfa Corpuscles, Alfa Corpuscles Private Limited, reported revenue of ₹2.01 Cr for FY 2024, up 41% year on year.
Alfa Corpuscles is involved in the innovation, design, manufacture, and sale of high-quality disposable medical devices. Based in New Delhi, India, the company focuses on healthcare solutions, particularly in the field of surgical consumables. Products such as Disposable Laparoscopy Access Trocars, Sterile Disposable Skin Staplers, Staple Removers, and Hernia Mesh Systems are developed to cater to patient needs. Advanced manufacturing facilities with clean rooms and in-house RD are utilized to ensure consistent quality and innovation in the medical sector.
Alfa Corpuscles offers Disposable Laparoscopy Access Trocar, Sterile Disposable Skin Stapler, Sterile Disposable Skin Staple Remover, and Hernia Mesh System.
Alfa Corpuscles has 4 investors. Key investors include Gujarat Venture Finance, Binoy Gardi, Chanderkant Patel, and Harsh Navinchandra Raval.
The valuation of Alfa Corpuscles is $3.45M as of Jan 2015.
Alfa Corpuscles operates through Alfa Corpuscles Private Limited.
The legal entities of Alfa Corpuscles currently have 2 directors, including Atul Sardana, Mihirkumar Arvind Joshi.